Pentasa 1gm Prolonged Release Granules 1s

Pentasa 1gm Prolonged Release Granules 1s is a specifically designed for the treatment of Ulcerative Colitis and Crohn’s Disease, both inflammatory bowel conditions. Mesalazine, an aminosalicylate, plays a crucial role in suppressing the production of inflammatory chemical messengers within the intestines, effectively reducing inflammation, ulceration, bleeding, and stomach pain associated with these gastrointestinal disorders.

Mesalazine functions by effectively suppressing the production of inflammatory chemical messengers in the intestines. This targeted action plays a pivotal role in mitigating symptoms associated with inflammatory bowel diseases, ultimately reducing inflammation, ulceration, bleeding, and stomach pain.

To ensure proper and effective use of it, containing Mesalazine is imperative to follow your doctors prescribed dose and duration. Before usage, refer to the label for specific directions.

While providing relief, Mesalazine may be associated with common side effects including stomach pain/epigastric pain, flatulence, headache, vomiting, diarrhea, nausea, abdominal pain, and rash. It's important to note that these side effects are generally mild and temporary.

Mesalazine tablets are not suitable for children under two years, and granules are not recommended for those below six years Inform your doctor of any existing kidney or liver issues. Any unusual symptoms should be promptly reported. Following a consistent dosing schedule is crucial for effective management. Alcohol consumption should be avoided during the course of treatment.

In case you forget to take a dose of medication take it as soon as remembered, or skip if it's almost time for the next dose. Adhering to the prescribed dosing schedule is essential for the optimal effectiveness of the medication. Consult with your healthcare professional if there are uncertainties or concerns about missed doses to ensure continued safe and effective treatment.